Risk of Clostridium difficile-Associated Disease Among Patients Receiving Proton-Pump Inhibitors in a Quebec Medical Intensive Care Unit
Authors:
- Mathieu BeaulieuMBMathieu Beaulieu
- Gilbert PichetteGPGilbert Pichette
- 1 November 2007
- journal article
- Published by Cambridge University Press (CUP) in Infection Control & Hospital Epidemiology
- Vol. 28 (11) , 1305-1307
Abstract
Our study was conducted to determine whether use of gastric acid-suppressive agents increased the risk of Clostridium difficile-associated disease (CDAD) in a medical intensive care unit of one of the first hospitals to be threatened by the current CDAD epidemic in Quebec, Canada. Our findings suggest that efforts to determine risk factors for CDAD should focus on other areas, such as older age and antibiotic use.Keywords
This publication has 10 references indexed in Scilit:
- C. difficile inquest too narrow as "Quebec strain" goes internationalCanadian Medical Association Journal, 2007
- Moxifloxacin Therapy as a Risk Factor forClostridium difficile–Associated Disease During an Outbreak: Attempts to Control a New Epidemic StrainInfection Control & Hospital Epidemiology, 2007
- A Hospital Outbreak of Diarrhea Due to an Emerging Epidemic Strain of Clostridium difficileArchives of internal medicine (1960), 2006
- Proton pump inhibitor therapy is a risk factor for Clostridium difficile‐associated diarrhoeaAlimentary Pharmacology & Therapeutics, 2006
- Emergence of Fluoroquinolones as the Predominant Risk Factor for Clostridium difficile-Associated Diarrhea: A Cohort Study during an Epidemic in QuebecClinical Infectious Diseases, 2005
- A Large Outbreak ofClostridium difficile–Associated Disease with an Unexpected Proportion of Deaths and Colectomies at a Teaching Hospital Following Increased Fluoroquinolone UseInfection Control & Hospital Epidemiology, 2005
- Hospitals battling outbreaks of C. difficileCanadian Medical Association Journal, 2004
- Risk of Clostridium difficile diarrhea among hospital inpatients prescribed proton pump inhibitors: cohort and case-control studiesCanadian Medical Association Journal, 2004
- Project IMPACT: Results from a Pilot Validity Study of a New Observational DatabaseCritical Care Medicine, 2002
- Laboratory Diagnosis of Clostridium difficile -Associated Diarrhea and Colitis: Usefulness of Premier Cytoclone A+B Enzyme Immunoassay for Combined Detection of Stool Toxins and Toxigenic C. difficile StrainsJournal of Clinical Microbiology, 2001